Skip to main content
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells.
Published Web Location
http://europepmc.org/articles/PMC3491838?pdf=renderNo data is associated with this publication.
Abstract
PARP inhibitors have been proposed as a potential targeted therapy for patients with triple-negative (ER-, PR-, HER2-negative) breast cancers. However, it is as yet unclear as to whether single agent or combination therapy using PARP inhibitors would be mo
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.